A SARS-CoV-2 Neutralizing Antibody Selected from COVID-19 Patients by Phage Display is Binding to the ACE2-RBD Interface and is Tolerant to Known RBD Mutations - Concepedia

Concepedia

Publication | Open Access

A SARS-CoV-2 Neutralizing Antibody Selected from COVID-19 Patients by Phage Display is Binding to the ACE2-RBD Interface and is Tolerant to Known RBD Mutations

DOI Full Paper Access

11

Citations

0

References

2020

Year

Federico Bertoglio, Viola Fühner, Maximilian Ruschig, Philip Alexander Heine, Ulfert Rand, Thomas Klünemann, Doris Meier, Nora Langreder, Stephan Steinke, Rico Ballmann,

SSRN Electronic Journal

No additional data available for this publication yet. Check back later!